257 related articles for article (PubMed ID: 16762794)
1. What is the economic value of digoxin therapy in congestive heart failure patients? Results from the DIG trial.
Eisenstein EL; Yusuf S; Bindal V; Bourassa MG; Horney A; Collins JF; Mark DB;
J Card Fail; 2006 Jun; 12(5):336-42. PubMed ID: 16762794
[TBL] [Abstract][Full Text] [Related]
2. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
[TBL] [Abstract][Full Text] [Related]
3. Economic implications of treatment guidelines for congestive heart failure.
Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
[TBL] [Abstract][Full Text] [Related]
4. Sex-based differences in the effect of digoxin for the treatment of heart failure.
Rathore SS; Wang Y; Krumholz HM
N Engl J Med; 2002 Oct; 347(18):1403-11. PubMed ID: 12409542
[TBL] [Abstract][Full Text] [Related]
5. The effect of digoxin on the quality of life in patients with heart failure.
Lader E; Egan D; Hunsberger S; Garg R; Czajkowski S; McSherry F
J Card Fail; 2003 Feb; 9(1):4-12. PubMed ID: 12612867
[TBL] [Abstract][Full Text] [Related]
6. Hospital cost effect of a heart failure disease management program: the Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial.
Gregory D; Kimmelstiel C; Perry K; Parikh A; Konstam V; Konstam MA
Am Heart J; 2006 May; 151(5):1013-8. PubMed ID: 16644325
[TBL] [Abstract][Full Text] [Related]
7. The effect of digoxin on mortality and morbidity in patients with heart failure.
Digitalis Investigation Group
N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306
[TBL] [Abstract][Full Text] [Related]
8. [Is digoxin effective in the treatment of heart insufficiency in patients with sinus rhythm?].
Henriksen OM; Gadsbøll N
Ugeskr Laeger; 1999 May; 161(22):3269-74. PubMed ID: 10485204
[TBL] [Abstract][Full Text] [Related]
9. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
Skrepnek GH; Abarca J; Malone DC; Armstrong EP; Shirazi FM; Woosley RL
Ann Pharmacother; 2005 Nov; 39(11):1785-91. PubMed ID: 16219900
[TBL] [Abstract][Full Text] [Related]
10. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
[TBL] [Abstract][Full Text] [Related]
11. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
12. Digoxin therapy for heart failure: an update.
Morris SA; Hatcher HF; Reddy DK
Am Fam Physician; 2006 Aug; 74(4):613-8. PubMed ID: 16939183
[TBL] [Abstract][Full Text] [Related]
13. Update on digoxin therapy in congestive heart failure.
Haji SA; Movahed A
Am Fam Physician; 2000 Jul; 62(2):409-16. PubMed ID: 10929703
[TBL] [Abstract][Full Text] [Related]
14. Economic analysis of a randomized trial of biventricular pacing in Canada.
Bentkover JD; Dorian P; Thibault B; Gardner M
Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313
[TBL] [Abstract][Full Text] [Related]
15. [Use of digitalis in chronic heart failure: an unresolved problem?].
Camerini A; Griffo R
Ital Heart J Suppl; 2001 Jan; 2(1):1-6. PubMed ID: 11216075
[TBL] [Abstract][Full Text] [Related]
16. Digoxin use and digoxin toxicity in the post-DIG trial era.
Hussain Z; Swindle J; Hauptman PJ
J Card Fail; 2006 Jun; 12(5):343-6. PubMed ID: 16762795
[TBL] [Abstract][Full Text] [Related]
17. Cost-consequences of ultrafiltration for acute heart failure: a decision model analysis.
Bradley SM; Levy WC; Veenstra DL
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):566-73. PubMed ID: 20031894
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
[TBL] [Abstract][Full Text] [Related]
19. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
[TBL] [Abstract][Full Text] [Related]
20. Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial.
Mark DB; Knight JD; Cowper PA; Davidson-Ray L; Anstrom KJ
Am Heart J; 2008 Oct; 156(4):698-705. PubMed ID: 18926150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
